Middle East Pharmaceutical Industries Company (TADAWUL:4016)
59.00
+1.15 (1.99%)
May 21, 2026, 3:19 PM AST
TADAWUL:4016 Balance Sheet
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 18.82 | 34.37 | 22.65 | 15.11 | 23.79 | 19.04 |
Cash & Short-Term Investments | 18.82 | 34.37 | 22.65 | 15.11 | 23.79 | 19.04 |
Cash Growth | -44.44% | 51.78% | 49.90% | -36.50% | 24.98% | 19.54% |
Accounts Receivable | 286.96 | 256.84 | 217.48 | 163.37 | 151.57 | 164.37 |
Other Receivables | - | 4.21 | 8.01 | 2.16 | 3.15 | 2.68 |
Receivables | 286.96 | 261.05 | 225.49 | 165.52 | 154.73 | 167.05 |
Inventory | 101.36 | 103.53 | 93.6 | 87.17 | 100.21 | 74.45 |
Prepaid Expenses | 21.72 | 4.45 | 4.12 | 2.74 | 3.41 | 3.26 |
Other Current Assets | - | 9.85 | 9.57 | 14.95 | 9.36 | 5.57 |
Total Current Assets | 428.86 | 413.25 | 355.42 | 285.49 | 291.5 | 269.37 |
Property, Plant & Equipment | 133.87 | 123.92 | 120.76 | 119.08 | 105.86 | 103.45 |
Long-Term Investments | - | - | - | 1.32 | 3.61 | 9.82 |
Other Intangible Assets | 63.75 | 62.36 | 50.59 | 46.85 | 41.49 | 34.29 |
Total Assets | 626.48 | 599.53 | 526.78 | 452.74 | 442.45 | 416.93 |
Accounts Payable | 45.86 | 44.02 | 27.35 | 28.04 | 37.95 | 32.73 |
Accrued Expenses | 39.02 | 25.38 | 26.44 | 16.58 | 10.91 | 7.31 |
Short-Term Debt | 50.1 | 37.39 | 60.09 | 52.5 | 69.13 | 66.44 |
Current Portion of Long-Term Debt | 5.06 | 4.57 | 3.17 | 6.34 | 6.34 | 4.75 |
Current Portion of Leases | 0.31 | 0.31 | - | - | - | - |
Current Income Taxes Payable | 9.93 | 7.69 | 7.09 | 5.43 | 5.59 | 4.79 |
Other Current Liabilities | - | 12.66 | 9.89 | 12.2 | 1.68 | 1.37 |
Total Current Liabilities | 150.28 | 132.02 | 134.04 | 121.08 | 131.59 | 117.39 |
Long-Term Debt | 27.8 | 21.41 | - | 3.17 | 9.51 | 15.84 |
Long-Term Leases | 0.16 | 0.16 | - | - | - | - |
Pension & Post-Retirement Benefits | 30.78 | 29.69 | 24.54 | 22.1 | 21.08 | 16.61 |
Total Liabilities | 209.03 | 183.29 | 158.57 | 146.35 | 162.18 | 149.85 |
Common Stock | 200 | 200 | 200 | 200 | 200 | 60 |
Retained Earnings | 230.47 | 229.97 | 179.96 | 133.07 | 104.63 | 221.53 |
Comprehensive Income & Other | -13.02 | -13.73 | -11.75 | -26.67 | -24.36 | -14.45 |
Shareholders' Equity | 417.45 | 416.24 | 368.21 | 306.4 | 280.27 | 267.08 |
Total Liabilities & Equity | 626.48 | 599.53 | 526.78 | 452.74 | 442.45 | 416.93 |
Total Debt | 83.44 | 63.84 | 63.26 | 62 | 84.97 | 87.04 |
Net Cash (Debt) | -64.62 | -29.47 | -40.61 | -46.9 | -61.18 | -68 |
Net Cash Per Share | -1.85 | -0.84 | -1.16 | -1.34 | -1.75 | -1.94 |
Filing Date Shares Outstanding | 20.07 | 35 | 35 | 35 | 35 | 35 |
Total Common Shares Outstanding | 20.07 | 35 | 35 | 35 | 35 | 35 |
Working Capital | 278.57 | 281.23 | 221.39 | 164.41 | 159.91 | 151.98 |
Book Value Per Share | 20.80 | 11.89 | 10.52 | 8.75 | 8.01 | 7.63 |
Tangible Book Value | 353.7 | 353.88 | 317.62 | 259.55 | 238.79 | 232.79 |
Tangible Book Value Per Share | 17.62 | 10.11 | 9.07 | 7.42 | 6.82 | 6.65 |
Land | - | 15.83 | 15.83 | 15.83 | 10.19 | 10.19 |
Buildings | - | 96.6 | 96.36 | 89.12 | 86.53 | 54.19 |
Machinery | - | 93.69 | 84.29 | 61.65 | 56.99 | 52.95 |
Construction In Progress | - | 9.74 | 4.9 | 24.99 | 17.33 | 46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.